title: Can we "terminate" alloimmune platelet transfusion refractoriness?
authors.affiliation: Blood Systems, Inc., Scottsdale, AZ.
authors.forename: Ralph R
authors.initials: RR
authors.lastname: Vassallo
authors.affiliation: Blood Systems Research Institute, San Francisco, CA.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Norris
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology*; D007518:Isoantibodies / Q000276:immunology*; D017713:Platelet Transfusion / Q000009:adverse effects*; D065227:Transfusion Reaction / Q000276:immunology*
chemical_list: D006649:Histocompatibility Antigens; D007518:Isoantibodies